Skip to content
HowShorted

TransMedics Group, Inc. short interest in 2020

In 2020, TransMedics Group, Inc.'s disclosed short interest ran from 7.46% of shares outstanding on 15 Jan 2020 to 3.13% on 31 Dec 2020, a change of -4.33 percentage points. The year's high was 9.48% on 29 May 2020 and its low 3.09% on 15 Dec 2020, averaging 5.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.55 days on 15 May 2020. Full history: TransMedics Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TransMedics Group, Inc. in 2020

2020 in figures

Start of year
7.46% (15 Jan 2020)
End of year
3.13% (31 Dec 2020)
Change
-4.33 pp
High
9.48% (29 May 2020)
Low
3.09% (15 Dec 2020)
Average
5.53%
Highest days to cover
19.55 (15 May 2020)
SEC filings marked
9

Every report in 2020

TransMedics Group, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20207.46%10.70
31 Jan 20206.71%8.59
14 Feb 20206.85%17.64
28 Feb 20207.18%10.27
13 Mar 20207.40%9.13results (8-K)
31 Mar 20206.58%10.5010-K filed
15 Apr 20206.21%9.75results (8-K)
30 Apr 20206.13%14.60
15 May 20206.31%19.5510-Q filed, results (8-K)
29 May 20209.48%6.41
15 Jun 20205.08%5.61
30 Jun 20206.15%6.46
15 Jul 20206.81%12.81
31 Jul 20204.78%10.51
14 Aug 20204.35%8.79results (8-K), 10-Q filed
31 Aug 20204.31%11.06
15 Sep 20205.11%11.30
30 Sep 20205.90%4.07
15 Oct 20203.54%7.12
30 Oct 20203.22%14.67
13 Nov 20203.55%14.72results (8-K), 10-Q filed
30 Nov 20203.45%16.38
15 Dec 20203.09%18.01
31 Dec 20203.13%8.88

See also: TransMedics Group, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.